The risk of peritonitis was decreased by 57% in patients treated with oral active vitamin D (HR 0.43; 95% CI 0.28–0.64; adjusted for albumin, hemoglobin, age, renal disease, peripheral vascular disease, diabetes, center, and year of start of PD). Here, ALB is linked to kidney disorder.